HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Topoisomerase III-β is required for efficient replication of positive-sense RNA viruses.

Abstract
Based on genome-scale loss-of-function screens we discovered that Topoisomerase III-β (TOP3B), a human topoisomerase that acts on DNA and RNA, is required for yellow fever virus and dengue virus-2 replication. Remarkably, we found that TOP3B is required for efficient replication of all positive-sense-single stranded RNA viruses tested, including SARS-CoV-2. While there are no drugs that specifically inhibit this topoisomerase, we posit that TOP3B is an attractive anti-viral target.
AuthorsK Reddisiva Prasanth, Minato Hirano, W Samuel Fagg, Eileen T McAnarney, Chao Shan, Xuping Xie, Adam Hage, Colette A Pietzsch, Alexander Bukreyev, Ricardo Rajsbaum, Pei-Yong Shi, Mark T Bedford, Shelton S Bradrick, Vineet Menachery, Mariano A Garcia-Blanco
JournalAntiviral research (Antiviral Res) Vol. 182 Pg. 104874 (10 2020) ISSN: 1872-9096 [Electronic] Netherlands
PMID32735900 (Publication Type: Journal Article)
CopyrightCopyright © 2020 The Author(s). Published by Elsevier B.V. All rights reserved.
Chemical References
  • TOP3B protein, human
  • DNA Topoisomerases, Type I
Topics
  • Betacoronavirus (physiology)
  • Cell Line
  • DNA Topoisomerases, Type I (metabolism)
  • Dengue Virus (physiology)
  • Ebolavirus (physiology)
  • Gene Knockout Techniques
  • Humans
  • Influenza A virus (physiology)
  • RNA Viruses (metabolism)
  • SARS-CoV-2
  • Virus Replication (physiology)
  • Yellow fever virus (physiology)
  • Zika Virus (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: